143 related articles for article (PubMed ID: 34184117)
1. Cationic Polyelectrolyte Nanocapsules of Moxifloxacin for Microbial Keratitis Therapy: Development, Characterization, and Pharmacodynamic Study.
Mohan P; Kesavan K
AAPS PharmSciTech; 2021 Jun; 22(5):195. PubMed ID: 34184117
[TBL] [Abstract][Full Text] [Related]
2. Cationic Chitosan/Pectin Polyelectrolyte Nanocapsules of Moxifloxacin as Novel Topical Management System for Bacterial Keratitis.
Mohan P; Rangari VD; Kesavan K
Curr Eye Res; 2022 Nov; 47(11):1498-1507. PubMed ID: 36099026
[TBL] [Abstract][Full Text] [Related]
3. Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study.
Dubey V; Mohan P; Dangi JS; Kesavan K
Int J Biol Macromol; 2020 Jun; 152():1224-1232. PubMed ID: 31751741
[TBL] [Abstract][Full Text] [Related]
4. An Improvement of the Efficacy of Moxifloxacin HCl for the Treatment of Bacterial Keratitis by the Formulation of Ocular Mucoadhesive Microspheres.
Dandagi PM; Belekar AM; Mastiholimath VS; Gadad AP; Sontake VW; Salian PS
Sci Pharm; 2013; 81(1):259-80. PubMed ID: 23641344
[TBL] [Abstract][Full Text] [Related]
5. Ocular Permeation of Topical Tazocin and Its Effectiveness in the Treatment of Pseudomonas aeruginosa Induced Keratitis in Rabbits.
Singh S; Agarwal R; Razak ZA; Ngu R; Nyein LL; Vasudevan S; Kapitonova M; Kadir AJ; Visvaraja S
J Ocul Pharmacol Ther; 2018; 34(1-2):214-223. PubMed ID: 29341837
[TBL] [Abstract][Full Text] [Related]
6. Investigating The Retention Potential of Chitosan Nanoparticulate Gel: Design, Development,
Kaul S; Jain N; Pandey J; Nagaich U
Recent Pat Antiinfect Drug Discov; 2020; 15(1):41-67. PubMed ID: 31612834
[TBL] [Abstract][Full Text] [Related]
7. Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis.
Bharti SK; Kesavan K
Ocul Immunol Inflamm; 2017 Aug; 25(4):463-474. PubMed ID: 26943481
[TBL] [Abstract][Full Text] [Related]
8. An Ex Vivo Evaluation of Moxifloxacin Nanostructured Lipid Carrier Enriched In Situ Gel for Transcorneal Permeation on Goat Cornea.
Gade S; Patel KK; Gupta C; Anjum MM; Deepika D; Agrawal AK; Singh S
J Pharm Sci; 2019 Sep; 108(9):2905-2916. PubMed ID: 30978345
[TBL] [Abstract][Full Text] [Related]
9. Hydroxypropyl methacrylamide-based copolymeric nanoparticles loaded with moxifloxacin as a mucoadhesive, cornea-penetrating nanomedicine eye drop with enhanced therapeutic benefits in bacterial keratitis.
Ch S; Mishra P; Bhatt H; Ghosh B; Roy S; Biswas S
Colloids Surf B Biointerfaces; 2021 Dec; 208():112113. PubMed ID: 34562784
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the potential of drug eluting contact lenses for treatment of bacterial keratitis using an ex vivo corneal model.
Ubani-Ukoma U; Gibson D; Schultz G; Silva BO; Chauhan A
Int J Pharm; 2019 Jun; 565():499-508. PubMed ID: 31085257
[TBL] [Abstract][Full Text] [Related]
11. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-poly(lactide-co-glycolide)/poloxamer mixed micelles as a mucoadhesive thermo-responsive moxifloxacin eye drop to improve treatment efficacy in bacterial keratitis.
Ch S; Padaga SG; Ghosh B; Roy S; Biswas S
Carbohydr Polym; 2023 Jul; 312():120822. PubMed ID: 37059521
[TBL] [Abstract][Full Text] [Related]
13. Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in-vitro, in-vivo evaluation.
Mahor A; Prajapati SK; Verma A; Gupta R; Iyer AK; Kesharwani P
J Colloid Interface Sci; 2016 Dec; 483():132-138. PubMed ID: 27552421
[TBL] [Abstract][Full Text] [Related]
14. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
15. Corneal delivery of moxifloxacin and dexamethasone combination using drug-eluting mucoadhesive contact lens to treat ocular infections.
Gade SK; Nirmal J; Garg P; Venuganti VVK
Int J Pharm; 2020 Dec; 591():120023. PubMed ID: 33127488
[TBL] [Abstract][Full Text] [Related]
16. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
Chojnacki M; Philbrick A; Wucher B; Reed JN; Tomaras A; Dunman PM; Wozniak RAF
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
[No Abstract] [Full Text] [Related]
17. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
Mannis MJ
Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies for ciprofloxacin hydrochloride pre-formed gels and thermally triggered (in situ) gels: in vitro and in vivo appraisal using a bacterial keratitis model in rabbits.
Abdelkader H; Mansour HF
Pharm Dev Technol; 2015 Jun; 20(4):410-6. PubMed ID: 24392945
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin.
Sebastián-Morelló M; Calatayud-Pascual MA; Rodilla V; Balaguer-Fernández C; López-Castellano A
Drug Deliv Transl Res; 2018 Feb; 8(1):132-139. PubMed ID: 29134554
[TBL] [Abstract][Full Text] [Related]
20. Reversible antibiotic loading and pH-responsive release from polymer brushes on contact lenses for therapy and prevention of corneal infections.
Guo Y; Qian S; Wang L; Zeng J; Miao R; Meng Y; Jin Y; Chen H; Wang B
J Mater Chem B; 2020 Nov; 8(44):10087-10092. PubMed ID: 32844863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
